pclx-001
pacylex pharmaceuticals
['leukemia', 'pclx-001', 'genesis,(-pathogenesis),(-carginogenesis)', 'pclx001', 'lymphoma', 'pacylex']
new invitro data demonstrates that pclx-001, a proprietary, potent, n-myristoyltransferase (nmt) inhibitor reduces angiogenesis, cell migration/invasion, and potentially cancer metastasis. #aacr23 #data #leukemia #lymphoma #cancer #pclx001 
Emerging biotech oncology company. Recently Closed Series A Funding to Advance Oncology Program into the Clinic.